[Informe de investigación] El mercado del genoma digital se valoró en 11.065,31 millones de dólares en 2019 y se prevé que alcance los 20.812,81 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 8,4 % entre 2020 y 2027.
El genoma digital es un conjunto digital completo de material genético presente en un organismo o una célula. . La tecnología del genoma digital se ocupa de los genes y sus funciones para encontrar las causas de las enfermedades crónicas y también para solucionarlas. La tecnología está asociada a los avances que ayudan a que la atención sanitaria sea más personal y más eficaz para el tratamiento. Además, el genoma digital es una forma más sencilla de recopilar información sobre la enfermedad crónica. Los profesionales utilizan la tecnología para observar más de cerca enfermedades de composición genética, como el cáncer. El genoma digital actúa como un soporte que permite el acceso instantáneo a combinaciones de rasgos para resolver consultas personalizadas aparentemente interminables.
regiones lucrativas para el mercado del genoma digital
Perspectivas del mercado
Creciente financiación para la genómica
La tecnología de secuenciación genómica está pasando rápidamente a la práctica clínica La práctica y la implementación de los mismos en los sistemas de salud han sido respaldadas por una inversión gubernamental sustancial, que representa ~4 mil millones de dólares en al menos 14 países. Estas iniciativas nacionales de medicina genómica están impulsando un cambio transformador en condiciones de la vida real y, al mismo tiempo, abordan las barreras para implementar y recopilar evidencia para una adopción más amplia, impulsando así el crecimiento del mercado. Además, el Reino Unido ha anunciado el proyecto genómico más grande del mundo como parte de una colaboración público-privada de 200 millones de dólares entre organizaciones benéficas y farmacéuticas. El Reino Unido ya ha desarrollado la base de datos genómica más grande del mundo a través del Proyecto 100.000 Genomas. Liderado por Innovate UK como parte de Investigación e Innovación del Reino Unido, el proyecto financiará a investigadores y a la industria para combinar datos y evidencia del mundo real de los servicios de salud del Reino Unido y crear nuevos productos y servicios que diagnostiquen enfermedades de manera eficiente. Además, en noviembre de 2018, Stilla Technologies anunció que había completado una ronda de financiación Serie A de 18,3 millones de dólares (€16 millones) liderada por Illumina Ventures. La empresa utilizará los fondos para comercializar su sistema de PCR digital Naica y desarrollar aplicaciones clínicas.
Debido a la financiación continua por parte de los fabricantes y el gobierno en el campo de la genómica, Se espera que el mercado del genoma digital experimente un crecimiento durante el período de pronóstico.
Información basada en el producto
Basado en el producto, El mercado del genoma digital se segmenta en análisis de ADN/ARN, chips de secuenciación, instrumentos analizadores y de secuenciación, instrumentos de preparación de muestras, software de análisis y secuenciación. El segmento de instrumentos de secuenciación y análisis tuvo la mayor participación del mercado en 2019, debido a ventajas como la creciente adopción de la secuenciación de instrumentos de análisis por parte de compañías farmacéuticas y biofarmacéuticas en economías avanzadas. Además, las empresas se están centrando en suministrar instrumentos de calidad superior a centros de investigación y empresas farmacéuticas que participan en el desarrollo de terapias para enfermedades genéticas. Por ejemplo, Thermo Fisher Scientific anunció el lanzamiento de su sistema Ion Torrent Genexus, la primera plataforma de secuenciación NGS de próxima generación totalmente integrada que presenta un flujo de trabajo automatizado de muestra a informe que ofrece resultados de forma económica en un solo día.
Mercado global del genoma digital, por producto: 2019 y 2027
Información basada en aplicaciones
Basado en la aplicación, el mercado del genoma digital se segmenta en diagnóstico, investigación agrícola, académica, descubrimiento de fármacos, medicina personalizada y otras aplicaciones. En 2019, el segmento de diagnóstico ocupó la mayor participación del mercado mundial del genoma digital debido a factores como el lanzamiento de productos de diagnóstico innovadores, el aumento de la inversión en tecnologías del genoma y la ampliación de las capacidades del genoma digital en aplicaciones de diagnóstico. Por ejemplo, en abril de 2020, Personal Genome Diagnostics, la empresa dedicada al desarrollo de un nuevo kit de diagnóstico para el perfil genómico de diferentes cánceres, recibió la aprobación de la FDA para su prueba completa de tejido PGDx elio.
< /p>
Información basada en el usuario final
Según el usuario final, el mercado del genoma digital se segmenta en laboratorios forenses y de diagnóstico, institutos de investigación académica, hospitales y otros usuarios finales. El segmento de laboratorios forenses y de diagnóstico tuvo la mayor participación del mercado en 2019, debido al creciente énfasis en la adopción de genomas digitales en laboratorios forenses y de diagnóstico. Además, el reciente avance tecnológico ayudará a resolver más casos en menos tiempo y generará pistas de investigación para casos que habrían llegado a callejones sin salida y ofrecerá oportunidades lucrativas durante el período previsto. Por ejemplo, la tecnología Illumina SBS, el sistema MiSeq FGx, es el primer sistema NGS diseñado específicamente para aplicaciones genómicas forenses.
Información estratégica
Las empresas suelen adoptar lanzamientos de productos y estrategias de expansión para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Esta estrategia es la más comúnmente adoptada por los actores del mercado para expandir su cartera de productos.
Los actores del mercado que operan en el mercado del genoma digital adoptaron la estrategia de innovación de productos para satisfacer la cambiante demanda de los clientes en todo el mundo. lo que también permite a los jugadores mantener su marca a nivel mundial.
Mercado del Genoma Digital: Por producto
- Instrumentos analizadores y de secuenciación
- Análisis de ADN/ARN
- Chips de secuenciación
- Instrumentos de preparación de muestras,
- Software de secuenciación y análisis
Mercado del genoma digital: ndash; Por aplicación
- Diagnóstico
- Agrícola
- Investigación académica
- Descubrimiento de fármacos
- Medicina personalizada
- Otra aplicación
Mercado del genoma digital: ndash; Por usuario final
- Laboratorios de diagnóstico y forense
- Institutos de investigación académica
- Hospitales
- Otro usuario final < /ul>
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico(APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- América del Sur (SAM)
- Brasil
- Argentina
- Resto de SAM
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
Mercado del Genoma Digital– Por geografía
Perfiles de empresas
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Digital genome is a technology which deals with the genes and their functions to help to find the causes behind the chronic diseases and also to fix them. Digital genome is a complete digital set of genetic material that present in an organism or a cell. The technology is associated with the advancements that helps to make healthcare more personal and more effective for the treatment. Moreover, the digital genome is an easier way to gathering the information about the chronic disease. The technology is used by the professionals to get a closer look of genetic composed diseases, such as cancer. A digital genome act as a supporter that enables instant access to trait combinations to solve apparently endless custom queries.
The factors that are driving growth of the market are increasing prevalence of increasing prevalence of chronic diseases, and growing funding for genomics. Moreover, increasing technological advancement in digital genome field are offering lucrative opportunities for the growth of the market.
The digital genome market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC., F. HOFFMANN-LA ROCHE LTD, Illumina, Inc., QIAGEN, GenomeMe, NanoString Technologies, Inc., BD, bioMerieux SA, GenMark Diagnostics, Inc., and Perkin Elmer, Inc. among others.
The List of Companies - Digital Genome Market
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
May 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
May 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
May 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)